Search Results 541-550 of 18307 for prostate cancer
... cancer cells survive after androgen ablation, the most common therapy for advanced prostate cancer. Prostate cancer is initially an androgen-dependent tumor.
Request Appointment · Mayo Gets FDA Approval for New Imaging Agent for Recurrent Prostate Cancer: Radiology.
Learn about detection, diagnostic approaches, treatment options and advances for prostate cancer, including robotic prostatectomy and current research.
The purpose of this trial is to investigate the effect that proton-based SABR has on quality-of-life in patients with localized prostate cancer. The ...
This is a biomarker preselected, randomized, open-label, multicenter, phase II study in men with metastatic castration resistant prostate cancer (mCRPC).
Health Education & Content Services. Your robotic-assisted prostate surgery. Mayo Clinic; 2024. Surgery for prostate cancer. Prostate Cancer Foundation. https ...
The purpose of this study is to determine whether an empty bladder during radiation therapy delivery for prostate cancer affects patient-reported urinary ...
Biomarkers from circulating cell-free tumor DNA in peripheral blood will identify patients with metastatic prostate cancer diagnosed with C11 choline PET/CT who ...
... prostate conditions, such as prostate cancer and enlarged prostate. TRUS images also can help guide prostate procedures and treatments. TRUS can make ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.